This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
Audiences:
Health Professionals
International Agencies
Policy Makers
Focus Area:
TB
Subjects:
MDR TB
Treatment- TB Disease
TB Treatment
Treatment- Medication Information
Extensively Drug-Resistant TB (XCR TB)
Publication Date:
2016
Format:
Report
Last Updated Date:
Publication ID:
34006